Literature DB >> 33746447

Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation.

Hasen A Al-Ghamdi1, Fayza F Al Fayez1, Abdulhadi I Bima1, Taghreed M Khawaji1, Ayman Z Elsamanoudy1,2.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a pathological process characterized by excessive hepatic fatty deposition with possible involvement of vitamin D deficiency and cellular senescence. The aim of this study is to investigate the pathophysiologic role of vitamin D deficiency and cellular senescence in NAFLD development. Moreover, it aims to investigate the potential protective role of vitamin D supplementation.
METHODS: This is an experimental Case/Control study. Forty-five male albino rats were enrolled in this study. Animals were divided into four groups: negative and positive control groups (10 for each group), a model of NAFLD (11) and vitamin D-treated NAFLD groups (14). At the end of the experiment, all rats were subjected to the following investigation; biochemical estimation of serum 25 hydroxycholecalciferol, senescence marker protein-30 (SMP-30), lipid profile and calculation of homeostatic model of insulin resistance (HOMA-IR).
RESULTS: NAFLD group shows a significant increase in glucose, insulin levels, and HOMA- IR compared with both normal controls. This finding indicates the intimate association between insulin resistance and NAFLD pathogenesis. Moreover, it was found that NAFLD group shows a significant decrease in SMP-30 level compared with normal controls. While vitamin D-treated NAFLD group shows significant increased SMP-30 and decrease in HOMA-IR in comparison with nontreated NAFLD group.
CONCLUSION: Vitamin D deficiency and increased cellular senescence are key features of NAFLD. Vitamin D supplementation could play a protective role, which needs further investigation including clinical human study.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALP, alkaline phosphatase; ALT, alanine transaminase enzyme; AST, aspartate transaminase enzyme; GGT, γ glutamyltranspeptidase; HOMA-IR; HOMA-IR, homeostatic model of insulin resistance; IR, insulin resistance; NAFLD; NAFLD, nonalcoholic fatty liver disease; NASH, steatohepatitis; SMP-30; SMP-30, senescence marker protein - 30; cellular senescence; vitamin D

Year:  2020        PMID: 33746447      PMCID: PMC7952998          DOI: 10.1016/j.jceh.2020.07.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  46 in total

Review 1.  The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis.

Authors:  Alkistis-Maria Papatheodoridi; Lampros Chrysavgis; Michael Koutsilieris; Antonios Chatzigeorgiou
Journal:  Hepatology       Date:  2019-12-18       Impact factor: 17.425

Review 2.  Dyslipidemia in nonalcoholic fatty liver disease.

Authors:  Antonio J Amor; Verónica Perea
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-04       Impact factor: 3.243

3.  Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.

Authors:  Arun J Sanyal; Scott L Friedman; Arthur J McCullough; Lara Dimick-Santos
Journal:  Hepatology       Date:  2015-03-19       Impact factor: 17.425

4.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.

Authors:  Douglas Osei-Hyiaman; Jie Liu; Liang Zhou; Grzegorz Godlewski; Judith Harvey-White; Won-il Jeong; Sándor Bátkai; Giovanni Marsicano; Beat Lutz; Christoph Buettner; George Kunos
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

5.  Clinicopathological Studies on Vitamin D(3) Toxicity and Therapeutic Evaluation of Aloe vera in Rats.

Authors:  Sambhaji G Chavhan; R S Brar; H S Banga; H S Sandhu; S Sodhi; P D Gadhave; V R Kothule; A M Kammon
Journal:  Toxicol Int       Date:  2011-01

6.  Cellular senescence drives age-dependent hepatic steatosis.

Authors:  Mikolaj Ogrodnik; Satomi Miwa; Tamar Tchkonia; Dina Tiniakos; Caroline L Wilson; Albert Lahat; Christoper P Day; Alastair Burt; Allyson Palmer; Quentin M Anstee; Sushma Nagaraja Grellscheid; Jan H J Hoeijmakers; Sander Barnhoorn; Derek A Mann; Thomas G Bird; Wilbert P Vermeij; James L Kirkland; João F Passos; Thomas von Zglinicki; Diana Jurk
Journal:  Nat Commun       Date:  2017-06-13       Impact factor: 14.919

Review 7.  Pathogenesis of non-alcoholic fatty liver disease.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  QJM       Date:  2009-11-13

8.  Dynamic modelling of pathways to cellular senescence reveals strategies for targeted interventions.

Authors:  Piero Dalle Pezze; Glyn Nelson; Elsje G Otten; Viktor I Korolchuk; Thomas B L Kirkwood; Thomas von Zglinicki; Daryl P Shanley
Journal:  PLoS Comput Biol       Date:  2014-08-28       Impact factor: 4.475

Review 9.  Adipokines as drug targets in diabetes and underlying disturbances.

Authors:  Vinícius Andrade-Oliveira; Niels O S Câmara; Pedro M Moraes-Vieira
Journal:  J Diabetes Res       Date:  2015-04-08       Impact factor: 4.011

10.  Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial.

Authors:  Mallikarjun Sakpal; Sandeep Satsangi; Manu Mehta; Ajay Duseja; Sanjay Bhadada; Ashim Das; Radha K Dhiman; Yogesh K Chawla
Journal:  JGH Open       Date:  2017-10-12
View more
  3 in total

Review 1.  Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease.

Authors:  Johanna Pedroza-Diaz; Johanna C Arroyave-Ospina; Sandra Serna Salas; Han Moshage
Journal:  Antioxidants (Basel)       Date:  2022-05-16

Review 2.  The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities.

Authors:  Abdulhadi Bima; Basmah Eldakhakhny; Dina Nuwaylati; Abrar Alnami; Mohammed Ajabnoor; Ayman Elsamanoudy
Journal:  Nutrients       Date:  2021-11-17       Impact factor: 5.717

Review 3.  Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD).

Authors:  Madhangi Parameswaran; Hamzah A Hasan; Jafor Sadeque; Sharan Jhaveri; Chaithanya Avanthika; Abimbola E Arisoyin; Maulik B Dhanani; Swaroopa M Rath
Journal:  Cureus       Date:  2021-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.